IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 108 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $145,000 | -28.2% | 110,000 | 0.0% | 0.01% | -28.6% |
| Q1 2018 | $202,000 | -56.5% | 110,000 | -50.0% | 0.01% | -12.5% |
| Q4 2017 | $464,000 | +89.4% | 220,000 | +100.0% | 0.01% | -11.1% |
| Q3 2017 | $245,000 | +29.6% | 110,000 | 0.0% | 0.01% | +28.6% |
| Q2 2017 | $189,000 | -30.5% | 110,000 | 0.0% | 0.01% | -22.2% |
| Q1 2017 | $272,000 | +64.8% | 110,000 | 0.0% | 0.01% | +80.0% |
| Q4 2016 | $165,000 | -41.5% | 110,000 | 0.0% | 0.01% | -37.5% |
| Q3 2016 | $282,000 | – | 110,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 474,609 | $626,000 | 0.55% |
| Kassirer Asset Management Corp | 325,800 | $430,000 | 0.28% |
| CORRADO ADVISORS, LLC | 104,850 | $138,000 | 0.08% |
| Artal Group S.A. | 2,750,000 | $3,630,000 | 0.08% |
| ROPES WEALTH ADVISORS LLC | 100,000 | $132,000 | 0.04% |
| MYCIO WEALTH PARTNERS, LLC | 246,527 | $325,000 | 0.03% |
| Palo Alto Investors LP | 616,355 | $814,000 | 0.03% |
| HOLLENCREST CAPITAL MANAGEMENT | 172,570 | $228,000 | 0.03% |
| LAU ASSOCIATES LLC | 26,713 | $35,000 | 0.02% |
| NATIXIS | 3,438,529 | $4,539,000 | 0.02% |